Spondyloarthritis & psoriatic arthritis

Comparison of clinical characteristics between patients with axial spondyloarthritis with and without acute anterior uveitis: a multicentre study of the Chinese Spondyloarthritis Registry

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

In Chinese patients with axSpA, older age at diagnosis, longer disease duration, presence of HLA-B27, current or past Achilles tendinitis, current or past dactylitis, current or past psoriasis, and a good response to NSAIDs were positively associated with AAU.

Study context

Population
Patients with axial spondyloarthritis (axSpA) in the Chinese Spondyloarthritis Registry, August 1, 2018–March 31, 2020
Participants
4,304 patients
Exposure
axSpA with vs without acute anterior uveitis (AAU)
Outcome
Clinical characteristics associated with AAU
Methodological detailsobservational, multicentre, registry-based, multivariate logistic regression
  • Observational
  • Multicentre
  • Registry-based
  • Multivariate logistic regression

Main finding

As reported in the abstract

Prevalence of AAU in axSpA

Prevalence of AAU

10.59%

Observational data: associations, not effects.

Further findings

Factors associated with AAU (multivariate logistic regression)

Age at diagnosis, OR 1.026
P < 0.001
Disease duration, OR 2.117
P < 0.001
Current or past Achilles tendinitis, OR 1.692
P < 0.001
Current or past dactylitis, OR 1.687
P = 0.002
Current or past psoriasis, OR 3.932
P < 0.001
Human leukocyte antigen-B27 (HLA-B27) presence, OR 2.787
P < 0.001
Good response to non-steroidal anti-inflammatory drugs (NSAIDs), OR 1.343
P = 0.027
  • Positive correlations

Original publication

Comparison of clinical characteristics between patients with axial spondyloarthritis with and without acute anterior uveitis: a multicentre study of the Chinese Spondyloarthritis Registry. Clin Exp Rheumatol. Published 6 October 2023. doi:10.55563/clinexprheumatol/icoqy3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.